1 Market Overview of Monoclonal Antibody for Multiple Myeloma 1.1 Monoclonal Antibody for Multiple Myeloma Market Overview 1.1.1 Monoclonal Antibody for Multiple Myeloma Product Scope 1.1.2 Monoclonal Antibody for Multiple Myeloma Market Status and Outlook 1.2 Global Monoclonal Antibody for Multiple Myeloma Market Size Overview by Region 2016 VS 2021VS 2027 1.3 Global Monoclonal Antibody for Multiple Myeloma Market Size by Region (2016-2027) 1.4 Global Monoclonal Antibody for Multiple Myeloma Historic Market Size by Region (2016-2021) 1.5 Global Monoclonal Antibody for Multiple Myeloma Market Size Forecast by Region (2022-2027) 1.6 Key Regions, Monoclonal Antibody for Multiple Myeloma Market Size (2016-2027) 1.6.1 North America Monoclonal Antibody for Multiple Myeloma Market Size (2016-2027) 1.6.2 Europe Monoclonal Antibody for Multiple Myeloma Market Size (2016-2027) 1.6.3 Asia-Pacific Monoclonal Antibody for Multiple Myeloma Market Size (2016-2027) 1.6.4 Latin America Monoclonal Antibody for Multiple Myeloma Market Size (2016-2027) 1.6.5 Middle East & Africa Monoclonal Antibody for Multiple Myeloma Market Size (2016-2027) 2 Monoclonal Antibody for Multiple Myeloma Market Overview by Type 2.1 Global Monoclonal Antibody for Multiple Myeloma Market Size by Type: 2016 VS 2021 VS 2027 2.2 Global Monoclonal Antibody for Multiple Myeloma Historic Market Size by Type (2016-2021) 2.3 Global Monoclonal Antibody for Multiple Myeloma Forecasted Market Size by Type (2022-2027) 2.4 Elotuzumab 2.5 Daratumumab 2.6 Siltuximab 2.7 Dacetuzumab 2.8 Rituximab 2.9 Other 3 Monoclonal Antibody for Multiple Myeloma Market Overview by Application 3.1 Global Monoclonal Antibody for Multiple Myeloma Market Size by Application: 2016 VS 2021 VS 2027 3.2 Global Monoclonal Antibody for Multiple Myeloma Historic Market Size by Application (2016-2021) 3.3 Global Monoclonal Antibody for Multiple Myeloma Forecasted Market Size by Application (2022-2027) 3.4 Hospital 3.5 Drug Center 3.6 Clinic 3.7 Other 4 Monoclonal Antibody for Multiple Myeloma Competition Analysis by Players 4.1 Global Monoclonal Antibody for Multiple Myeloma Market Size by Players (2016-2021) 4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Monoclonal Antibody for Multiple Myeloma as of 2020) 4.3 Date of Key Players Enter into Monoclonal Antibody for Multiple Myeloma Market 4.4 Global Top Players Monoclonal Antibody for Multiple Myeloma Headquarters and Area Served 4.5 Key Players Monoclonal Antibody for Multiple Myeloma Product Solution and Service 4.6 Competitive Status 4.6.1 Monoclonal Antibody for Multiple Myeloma Market Concentration Rate 4.6.2 Mergers & Acquisitions, Expansion Plans 5 Company (Top Players) Profiles and Key Data 5.1 Bristol Myers Squibb 5.1.1 Bristol Myers Squibb Profile 5.1.2 Bristol Myers Squibb Main Business 5.1.3 Bristol Myers Squibb Monoclonal Antibody for Multiple Myeloma Products, Services and Solutions 5.1.4 Bristol Myers Squibb Monoclonal Antibody for Multiple Myeloma Revenue (US$ Million) & (2016-2021) 5.1.5 Bristol Myers Squibb Recent Developments 5.2 Abbvie 5.2.1 Abbvie Profile 5.2.2 Abbvie Main Business 5.2.3 Abbvie Monoclonal Antibody for Multiple Myeloma Products, Services and Solutions 5.2.4 Abbvie Monoclonal Antibody for Multiple Myeloma Revenue (US$ Million) & (2016-2021) 5.2.5 Abbvie Recent Developments 5.3 Janssen Biotech 5.5.1 Janssen Biotech Profile 5.3.2 Janssen Biotech Main Business 5.3.3 Janssen Biotech Monoclonal Antibody for Multiple Myeloma Products, Services and Solutions 5.3.4 Janssen Biotech Monoclonal Antibody for Multiple Myeloma Revenue (US$ Million) & (2016-2021) 5.3.5 Karyopharm Therapeutics Recent Developments 5.4 Karyopharm Therapeutics 5.4.1 Karyopharm Therapeutics Profile 5.4.2 Karyopharm Therapeutics Main Business 5.4.3 Karyopharm Therapeutics Monoclonal Antibody for Multiple Myeloma Products, Services and Solutions 5.4.4 Karyopharm Therapeutics Monoclonal Antibody for Multiple Myeloma Revenue (US$ Million) & (2016-2021) 5.4.5 Karyopharm Therapeutics Recent Developments 5.5 PDL BioPharma 5.5.1 PDL BioPharma Profile 5.5.2 PDL BioPharma Main Business 5.5.3 PDL BioPharma Monoclonal Antibody for Multiple Myeloma Products, Services and Solutions 5.5.4 PDL BioPharma Monoclonal Antibody for Multiple Myeloma Revenue (US$ Million) & (2016-2021) 5.5.5 PDL BioPharma Recent Developments 5.6 Roche 5.6.1 Roche Profile 5.6.2 Roche Main Business 5.6.3 Roche Monoclonal Antibody for Multiple Myeloma Products, Services and Solutions 5.6.4 Roche Monoclonal Antibody for Multiple Myeloma Revenue (US$ Million) & (2016-2021) 5.6.5 Roche Recent Developments 5.7 Seattle Genetics 5.7.1 Seattle Genetics Profile 5.7.2 Seattle Genetics Main Business 5.7.3 Seattle Genetics Monoclonal Antibody for Multiple Myeloma Products, Services and Solutions 5.7.4 Seattle Genetics Monoclonal Antibody for Multiple Myeloma Revenue (US$ Million) & (2016-2021) 5.7.5 Seattle Genetics Recent Developments ... 6 North America 6.1 North America Monoclonal Antibody for Multiple Myeloma Market Size by Country (2016-2027) 6.2 United States 6.3 Canada 7 Europe 7.1 Europe Monoclonal Antibody for Multiple Myeloma Market Size by Country (2016-2027) 7.2 Germany 7.3 France 7.4 U.K. 7.5 Italy 7.6 Russia 7.7 Nordic 7.8 Rest of Europe 8 Asia-Pacific 8.1 Asia-Pacific Monoclonal Antibody for Multiple Myeloma Market Size by Region (2016-2027) 8.2 China 8.3 Japan 8.4 South Korea 8.5 Southeast Asia 8.6 India 8.7 Australia 8.8 Rest of Asia-Pacific 9 Latin America 9.1 Latin America Monoclonal Antibody for Multiple Myeloma Market Size by Country (2016-2027) 9.2 Mexico 9.3 Brazil 9.4 Rest of Latin America 10 Middle East & Africa 10.1 Middle East & Africa Monoclonal Antibody for Multiple Myeloma Market Size by Country (2016-2027) 10.2 Turkey 10.3 Saudi Arabia 10.4 UAE 10.5 Rest of Middle East & Africa 11 Monoclonal Antibody for Multiple Myeloma Market Dynamics 11.1 Monoclonal Antibody for Multiple Myeloma Industry Trends 11.2 Monoclonal Antibody for Multiple Myeloma Market Drivers 11.3 Monoclonal Antibody for Multiple Myeloma Market Challenges 11.4 Monoclonal Antibody for Multiple Myeloma Market Restraints 12 Research Finding /Conclusion 13 Methodology and Data Source 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Disclaimer 13.4 Author List

List of Tables Table 1. Global Market Monoclonal Antibody for Multiple Myeloma Market Size (US$ Million) Comparison by Region 2016 VS 2021 VS 2027 Table 2. Global Monoclonal Antibody for Multiple Myeloma Market Size by Region (2016-2021) & (US$ Million) Table 3. Global Monoclonal Antibody for Multiple Myeloma Market Size Share by Region (2016-2021) Table 4. Global Monoclonal Antibody for Multiple Myeloma Forecasted Market Size by Region (2022-2027) & (US$ Million) Table 5. Global Monoclonal Antibody for Multiple Myeloma Forecasted Market Size Share by Region (2022-2027) Table 6. Global Monoclonal Antibody for Multiple Myeloma Market Size (US$ Million) by Type: 2016 VS 2021 VS 2027 Table 7. Global Monoclonal Antibody for Multiple Myeloma Market Size by Type (2016-2021) & (US$ Million) Table 8. Global Monoclonal Antibody for Multiple Myeloma Revenue Market Share by Type (2016-2021) Table 9. Global Monoclonal Antibody for Multiple Myeloma Forecasted Market Size by Type (2022-2027) & (US$ Million) Table 10. Global Monoclonal Antibody for Multiple Myeloma Revenue Market Share by Type (2022-2027) Table 11. Global Monoclonal Antibody for Multiple Myeloma Market Size (US$ Million) by Application: 2016 VS 2021 VS 2027 Table 12. Global Monoclonal Antibody for Multiple Myeloma Market Size by Application (2016-2021) & (US$ Million) Table 13. Global Monoclonal Antibody for Multiple Myeloma Revenue Market Share by Application (2016-2021) Table 14. Global Monoclonal Antibody for Multiple Myeloma Forecasted Market Size by Application (2022-2027) & (US$ Million) Table 15. Global Monoclonal Antibody for Multiple Myeloma Revenue Market Share by Application (2022-2027) Table 16. Global Monoclonal Antibody for Multiple Myeloma Revenue (US$ Million) by Players (2016-2021) Table 17. Global Monoclonal Antibody for Multiple Myeloma Revenue Market Share by Players (2016-2021) Table 18. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Monoclonal Antibody for Multiple Myeloma as of 2020) Table 19. Date of Key Manufacturers Enter into Monoclonal Antibody for Multiple Myeloma Market Table 20. Global Monoclonal Antibody for Multiple Myeloma Top Players Headquarters and Area Served Table 21. Monoclonal Antibody for Multiple Myeloma Product Solution and Service Table 22. Global Monoclonal Antibody for Multiple Myeloma Players Market Concentration Ratio (CR5 and HHI) Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Bristol Myers Squibb Basic Information List Table 25. Bristol Myers Squibb Description and Business Overview Table 26. Bristol Myers Squibb Monoclonal Antibody for Multiple Myeloma Products, Services and Solutions Table 27. Revenue (US$ Million) in Monoclonal Antibody for Multiple Myeloma Business of Bristol Myers Squibb (2016-2021) Table 28. Bristol Myers Squibb Recent Developments Table 29. Abbvie Basic Information List Table 30. Abbvie Description and Business Overview Table 31. Abbvie Monoclonal Antibody for Multiple Myeloma Products, Services and Solutions Table 32. Revenue (US$ Million) in Monoclonal Antibody for Multiple Myeloma Business of Abbvie (2016-2021) Table 33. Abbvie Recent Developments Table 34. Janssen Biotech Basic Information List Table 35. Janssen Biotech Description and Business Overview Table 36. Janssen Biotech Monoclonal Antibody for Multiple Myeloma Products, Services and Solutions Table 37. Revenue (US$ Million) in Monoclonal Antibody for Multiple Myeloma Business of Janssen Biotech (2016-2021) Table 38. Janssen Biotech Recent Developments Table 39. Karyopharm Therapeutics Basic Information List Table 40. Karyopharm Therapeutics Description and Business Overview Table 41. Karyopharm Therapeutics Monoclonal Antibody for Multiple Myeloma Products, Services and Solutions Table 42. Revenue (US$ Million) in Monoclonal Antibody for Multiple Myeloma Business of Karyopharm Therapeutics (2016-2021) Table 43. Karyopharm Therapeutics Recent Developments Table 44. PDL BioPharma Basic Information List Table 45. PDL BioPharma Description and Business Overview Table 46. PDL BioPharma Monoclonal Antibody for Multiple Myeloma Products, Services and Solutions Table 47. Revenue (US$ Million) in Monoclonal Antibody for Multiple Myeloma Business of PDL BioPharma (2016-2021) Table 48. PDL BioPharma Recent Developments Table 49. Roche Basic Information List Table 50. Roche Description and Business Overview Table 51. Roche Monoclonal Antibody for Multiple Myeloma Products, Services and Solutions Table 52. Revenue (US$ Million) in Monoclonal Antibody for Multiple Myeloma Business of Roche (2016-2021) Table 53. Roche Recent Developments Table 54. Seattle Genetics Basic Information List Table 55. Seattle Genetics Description and Business Overview Table 56. Seattle Genetics Monoclonal Antibody for Multiple Myeloma Products, Services and Solutions Table 57. Revenue (US$ Million) in Monoclonal Antibody for Multiple Myeloma Business of Seattle Genetics (2016-2021) Table 58. Seattle Genetics Recent Developments Table 59. North America Monoclonal Antibody for Multiple Myeloma Market Size by Country (2016-2021) & (US$ Million) Table 60. North America Monoclonal Antibody for Multiple Myeloma Market Size by Country (2022-2027) & (US$ Million) Table 61. Europe Monoclonal Antibody for Multiple Myeloma Market Size by Country (2016-2021) & (US$ Million) Table 62. Europe Monoclonal Antibody for Multiple Myeloma Market Size by Country (2022-2027) & (US$ Million) Table 63. Asia-Pacific Monoclonal Antibody for Multiple Myeloma Market Size by Region (2016-2021) & (US$ Million) Table 64. Asia-Pacific Monoclonal Antibody for Multiple Myeloma Market Size by Region (2022-2027) & (US$ Million) Table 65. Asia-Pacific Monoclonal Antibody for Multiple Myeloma Market Share by Region (2016-2021) Table 66. Asia-Pacific Monoclonal Antibody for Multiple Myeloma Market Share by Region (2022-2027) Table 67. Latin America Monoclonal Antibody for Multiple Myeloma Market Size by Country (2016-2021) & (US$ Million) Table 68. Latin America Monoclonal Antibody for Multiple Myeloma Market Size by Country (2022-2027) & (US$ Million) Table 69. Middle East & Africa Monoclonal Antibody for Multiple Myeloma Market Size by Players (2016-2021) & (US$ Million) Table 70. Middle East & Africa Monoclonal Antibody for Multiple Myeloma Market Size by Country (2022-2027) & (US$ Million) Table 71. Monoclonal Antibody for Multiple Myeloma Market Trends Table 72. Monoclonal Antibody for Multiple Myeloma Market Drivers Table 73. Monoclonal Antibody for Multiple Myeloma Market Challenges Table 74. Monoclonal Antibody for Multiple Myeloma Market Restraints Table 75. Research Programs/Design for This Report Table 76. Key Data Information from Secondary Sources Table 77. Key Data Information from Primary Sources List of Figures Figure 1. Global Monoclonal Antibody for Multiple Myeloma Market Size Year-over-Year 2016-2027 & (US$ Million) Figure 2. Global Monoclonal Antibody for Multiple Myeloma Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 3. Global Monoclonal Antibody for Multiple Myeloma Market Share by Regions: 2021 VS 2027 Figure 4. Global Monoclonal Antibody for Multiple Myeloma Forecasted Market Size Share by Region (2022-2027) Figure 5. North America Monoclonal Antibody for Multiple Myeloma Market Size (US$ Million) Growth Rate (2016-2027) Figure 6. Europe Monoclonal Antibody for Multiple Myeloma Market Size (US$ Million) and Growth Rate (2016-2027) Figure 7. Asia-Pacific Monoclonal Antibody for Multiple Myeloma Market Size (US$ Million) and Growth Rate (2016-2027) Figure 8. Latin America Monoclonal Antibody for Multiple Myeloma Market Size (US$ Million) and Growth Rate (2016-2027) Figure 9. Middle East & Africa Monoclonal Antibody for Multiple Myeloma Market Size (US$ Million) and Growth Rate (2016-2027) Figure 10. Global Monoclonal Antibody for Multiple Myeloma Market Size Share by Type in 2021 & 2027 Figure 11. Elotuzumab Market Size (US$ Million) YoY Growth (2016-2027) Figure 12. Daratumumab Market Size (US$ Million) YoY Growth (2016-2027) Figure 13. Siltuximab Market Size (US$ Million) YoY Growth (2016-2027) Figure 14. Dacetuzumab Market Size (US$ Million) YoY Growth (2016-2027) Figure 15. Rituximab Market Size (US$ Million) YoY Growth (2016-2027) Figure 16. Other Market Size (US$ Million) YoY Growth (2016-2027) Figure 17. Global Monoclonal Antibody for Multiple Myeloma Market Size Share by Application in 2021 & 2027 Figure 18. Hospital Market Size (US$ Million) YoY Growth (2016-2027) Figure 19. Drug Center Market Size (US$ Million) YoY Growth (2016-2027) Figure 20. Clinic Market Size (US$ Million) YoY Growth (2016-2027) Figure 21. Other Market Size (US$ Million) YoY Growth (2016-2027) Figure 22. Monoclonal Antibody for Multiple Myeloma Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 23. Global Top 5 and Top 10 Players Monoclonal Antibody for Multiple Myeloma Market Share in 2020 Figure 24. North America Monoclonal Antibody for Multiple Myeloma Market Share by Country (2016-2027) Figure 25. United States Monoclonal Antibody for Multiple Myeloma Market Size (2016-2027) & (US$ Million) Figure 26. Canada Monoclonal Antibody for Multiple Myeloma Market Size (2016-2027) & (US$ Million) Figure 27. Germany Monoclonal Antibody for Multiple Myeloma Market Size (2016-2027) & (US$ Million) Figure 28. France Monoclonal Antibody for Multiple Myeloma Market Size (2016-2027) & (US$ Million) Figure 29. U.K. Monoclonal Antibody for Multiple Myeloma Market Size (2016-2027) & (US$ Million) Figure 30. Italy Monoclonal Antibody for Multiple Myeloma Market Size (2016-2027) & (US$ Million) Figure 31. Russia Monoclonal Antibody for Multiple Myeloma Market Size (2016-2027) & (US$ Million) Figure 32. Nordic Monoclonal Antibody for Multiple Myeloma Market Size (2016-2027) & (US$ Million) Figure 33. Rest of Europe Monoclonal Antibody for Multiple Myeloma Market Size (2016-2027) & (US$ Million) Figure 34. Asia-Pacific Monoclonal Antibody for Multiple Myeloma Market Share by Region (2016-2027) Figure 35. China Monoclonal Antibody for Multiple Myeloma Market Size (2016-2027) & (US$ Million) Figure 36. Japan Monoclonal Antibody for Multiple Myeloma Market Size (2016-2027) & (US$ Million) Figure 37. South Korea Monoclonal Antibody for Multiple Myeloma Market Size (2016-2027) & (US$ Million) Figure 38. Southeast Asia Monoclonal Antibody for Multiple Myeloma Market Size (2016-2027) & (US$ Million) Figure 39. India Monoclonal Antibody for Multiple Myeloma Market Size (2016-2027) & (US$ Million) Figure 40. Australia Monoclonal Antibody for Multiple Myeloma Market Size (2016-2027) & (US$ Million) Figure 41. Rest of Asia-Pacific Monoclonal Antibody for Multiple Myeloma Market Size (2016-2027) & (US$ Million) Figure 42. Latin America Monoclonal Antibody for Multiple Myeloma Market Share by Country (2016-2027) Figure 43. Mexico Monoclonal Antibody for Multiple Myeloma Market Size (2016-2027) & (US$ Million) Figure 44. Brazil Monoclonal Antibody for Multiple Myeloma Market Size (2016-2027) & (US$ Million) Figure 45. Rest of Latin America Monoclonal Antibody for Multiple Myeloma Market Size (2016-2027) & (US$ Million) Figure 46. Middle East & Africa Monoclonal Antibody for Multiple Myeloma Market Share by Country (2016-2027) Figure 47. Turkey Monoclonal Antibody for Multiple Myeloma Market Size (2016-2027) & (US$ Million) Figure 48. Saudi Arabia Monoclonal Antibody for Multiple Myeloma Market Size (2016-2027) & (US$ Million) Figure 49. UAE Monoclonal Antibody for Multiple Myeloma Market Size (2016-2027) & (US$ Million) Figure 50. Rest of Middle East & Africa Monoclonal Antibody for Multiple Myeloma Market Size (2016-2027) & (US$ Million) Figure 51. Bottom-up and Top-down Approaches for This Report Figure 52. Data Triangulation

Bristol Myers Squibb Abbvie Janssen Biotech Karyopharm Therapeutics PDL BioPharma Roche Seattle Genetics